- Title
- Unravelling the epigenome of myelodysplastic syndrome: diagnosis, prognosis, and response to therapy
- Creator
- Bond, Danielle R.; Lee, Heather J.; Enjeti, Anoop K.
- Relation
- Cancers Vol. 12, Issue 11, no. 3128
- Publisher Link
- http://dx.doi.org/10.3390/cancers12113128
- Publisher
- MDPI AG
- Resource Type
- journal article
- Date
- 2020
- Description
- Myelodysplastic syndrome (MDS) is a malignancy that disrupts normal blood cell production and commonly affects our ageing population. MDS patients are diagnosed using an invasive bone marrow biopsy and high-risk MDS patients are treated with hypomethylating agents (HMAs) such as decitabine and azacytidine. However, these therapies are only effective in 50% of patients, and many develop resistance to therapy, often resulting in bone marrow failure or leukemic transformation. Therefore, there is a strong need for less invasive, diagnostic tests for MDS, novel markers that can predict response to therapy and/or patient prognosis to aid treatment stratification, as well as new and effective therapeutics to enhance patient quality of life and survival. Epigenetic modifiers such as DNA methylation, long non-coding RNAs (lncRNAs) and micro-RNAs (miRNAs) are perturbed in MDS blasts and the bone marrow micro-environment, influencing disease progression and response to therapy. This review focusses on the potential utility of epigenetic modifiers in aiding diagnosis, prognosis, and predicting treatment response in MDS, and touches on the need for extensive and collaborative research using single-cell technologies and multi-omics to test the clinical utility of epigenetic markers for MDS patients in the future.
- Subject
- myelodysplastic syndrome; DNA methylation; long non-coding RNA; micro-RNA; diagnosis; prognosis; treatment; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1452750
- Identifier
- uon:44495
- Identifier
- ISSN:2072-6694
- Rights
- © This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
- Language
- eng
- Full Text
- Reviewed
- Hits: 727
- Visitors: 831
- Downloads: 110
Thumbnail | File | Description | Size | Format | |||
---|---|---|---|---|---|---|---|
View Details Download | ATTACHMENT02 | Publisher version (open access) | 1 MB | Adobe Acrobat PDF | View Details Download |